RxDoctor Payments Data

Harry Reynolds, MD

Dermatology · Charleston, WVNPI 1043277270

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,935 of the $2,210 with a category attached, or 87.6%. 11 manufacturers reported payments, led by Johnson & Johnson at 35.2% of the total. That places this record below the midpoint for dermatology clinicians in WV, where the typical reported total is $2,210.

$2,210in general payments, 2019–2025

Across 57 payments — averaging $38.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$779
  • AbbVie$418
  • E.r. Squibb & Sons, L.L.C.$368
  • Galderma Laboratories, L.p.$296
  • Janssen Scientific Affairs, LLC$95
  • Incyte Corporation$81
  • plus $173 from 5 others

What the payments were for

  • Food & beverage$1,93588%
  • Education$27512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,210 in reported general payments places this provider in the 50th percentile of 39 dermatology providers in West Virginia.

See all dermatology providers in West Virginia

Medicare billing

Part B allowed, 2024
$96,514
Medicare patients
224
Services billed
1,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast24$120,626
Clobetasol Propionate65$2,507
Metronidazole33$2,061
Ketoconazole51$1,333
Betamethasone Dipropionate23$1,113
Econazole Nitrate28$1,091
Imiquimod21$799
Desonide17$465
Doxycycline Hyclate25$275
Mometasone Furoate22$237
Acyclovir11$176
Triamcinolone Acetonide16$152
Mupirocin20$149
Amoxicillin19$117

Paid to pharmacies, not to this prescriber.

Other dermatology in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →